Видео ютуба по тегу Obroncology

Ivo Abraham, PhD, RN, explains the key features of a biosimilar
Ivo Abraham, PhD, RN, explains the key features of a biosimilar
Ivo Abraham, PhD, RN, discusses those biosimilars that are approved or close to approval
Ivo Abraham, PhD, RN, discusses those biosimilars that are approved or close to approval
Ivo Abraham, PhD, RN, speculates on the hurdles that could prevent the adoption of biosimilars
Ivo Abraham, PhD, RN, speculates on the hurdles that could prevent the adoption of biosimilars
Ivo Abraham, PhD, RN, comments on how we can demonstrate the value of cancer treatments
Ivo Abraham, PhD, RN, comments on how we can demonstrate the value of cancer treatments
Mary Kruczynski tells us how the Cost Drivers in Cancer Care study was developed
Mary Kruczynski tells us how the Cost Drivers in Cancer Care study was developed
Christopher Logothetis, MD, speculates on the cost implications of abiraterone
Christopher Logothetis, MD, speculates on the cost implications of abiraterone
Christopher Logothetis, MD, offers opinion on the efficacy of the AR-V7 test
Christopher Logothetis, MD, offers opinion on the efficacy of the AR-V7 test
Noa Biran, MD, shares how immunotherapies are being integrated into MM treatment algorithms
Noa Biran, MD, shares how immunotherapies are being integrated into MM treatment algorithms
Michael Diaz, MD, discusses the challenges in adopting quality and value measures
Michael Diaz, MD, discusses the challenges in adopting quality and value measures
Suanne Gersdorf, FACHE, MSB, shares how 340B has impacted her practice
Suanne Gersdorf, FACHE, MSB, shares how 340B has impacted her practice
Edith P. Mitchell, MD, explains how organoids are being used for cancer biology research
Edith P. Mitchell, MD, explains how organoids are being used for cancer biology research
Robert J. Brooks, MD, offers advantages and disadvantages of joining a large oncology group
Robert J. Brooks, MD, offers advantages and disadvantages of joining a large oncology group
William K. Oh, MD, offers opinion on the role of chemotherapy in the treatment of mCRPC
William K. Oh, MD, offers opinion on the role of chemotherapy in the treatment of mCRPC
Robert Figlin, MD, discusses recent progress in the treatment of renal cell cancer (RCC)
Robert Figlin, MD, discusses recent progress in the treatment of renal cell cancer (RCC)
Michael Diaz, MD, on how community oncology is shaping the future of cancer care
Michael Diaz, MD, on how community oncology is shaping the future of cancer care
Jennie Crews, MD, MMM, FACP, on embracing new value-based oncology models
Jennie Crews, MD, MMM, FACP, on embracing new value-based oncology models
Naiyer Rizvi, MD, offers thoughts on the role of blood TMB vs. tissue TMB
Naiyer Rizvi, MD, offers thoughts on the role of blood TMB vs. tissue TMB
Jeannie Brant, PhD, APRN, AOCN, FAAN, on the role of a medical home and palliative care
Jeannie Brant, PhD, APRN, AOCN, FAAN, on the role of a medical home and palliative care